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ABSTRACT 
 
 
 
 This project provides proof of concept for a microRNA "sponge", a novel microRNA 
sequestration technique which will aid characterization of the function of different microRNAs 
by showing the effects of the depletion of specific cellular microRNAs.  To prove that microRNA 
"sponges" will effectively bind and hold native microRNA in vitro, plasmids were constructed 
encoding luciferase reporter mRNAs whose 3’ UTRs contain four experimental sponges to bind 
either microRNA Let7 or miR122, or to contain two mutant sequences that do not bind miRNAs.  
The plasmids were transfected into Huh7 and Hela cell lines, and the levels of luciferase activity 
were quantified by luminescence.  The results showed a decreased luciferase activity for the 
sponge containing plasmids, but not the mutant plasmids, indicating they successfully bound 
their miRNAs to block reporter mRNA translation. 
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BACKGROUND 
 
 
  
 MicroRNAs 
 
Overview 
 
 MicroRNAs (miRNAs) are small RNA molecules found in the cytoplasm and nuclei of 
plants and animals. miRNAs are approximately 21 nucleotides long, and usually function by 
binding the 3'-untranslated regions (3'-UTR) of a target mRNA to block further translation of the 
mRNA, thus regulating the production of specific proteins (Lu et al., 2008).  It is estimated that 
1-4% of genes in the human genome encode miRNAs, and that any one miRNA could regulate 
up to 200 genes (Lim et al., 2003; Lu et al., 2008). 
 
miRNA Functions 
 Each miRNA is thought to regulate multiple genes.  Given the prediction that 200 to 500 
unique miRNAs may be present in eukaryotes, the potential range of regulatory functions for 
miRNAs is enormous (Lim et al., 2003).  It is expected that over one third of gene expression is 
regulated by miRNAs.  miRNAs have been implicated in the regulation of a diverse array of 
functions, including early development (Reinhart et al., 2000), cell proliferation, cell death 
(Brennecke et al., 2003), apoptosis, fat metabolism (Xu et al., 2003), and cell differentiation 
(Dostie et al., 2003).  Recent studies have revealed possible links between miRNA and cancer 
(Michael et al, 2003; Calin et al, 2004) , viral disease (Pfeffer et al., 2004), and developmental 
diseases (Krichevsky et al., 2003).  
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miRNA Mechanisms 
 The vast majority of miRNAs studied in animals act to regulate protein levels of a 
targeted gene or genes, apparently without affecting the levels of the corresponding mRNAs. 
This situation contrasts with the function of small interfering RNAs (siRNAs) where the target 
mRNAs are usually cleaved and degraded (Chu and Rana, 2006).  Studies on miRNAs from C. 
elegans show that miRNA does not affect mRNA polyA tail length, transport by exportin-5 into 
the cytoplasm, nor entry into the appropriate polysomes for translation. Thus, steps downstream 
from translation are likely influenced by miRNA function (Olsen and Ambros, 1999).  
 The RNA-induced silencing complex (RISC) is understood to be a major factor in 
blocking translation of mRNA, and is already known to be an important part of how siRNAs 
function to regulate protein levels. RISC is the primary molecule employed by cells to regulate 
the induced silencing of mRNA translation. The miRNA must associate with RISC in order to 
accomplish this regulation of translation.  Immunoprecipitation with antibodies against RISC 
yields endogenous miRNAs, providing further evidence that RISC most likely associates with 
miRNAs in vivo. miRNAs in animals bind imperfectly to its binding site, presenting a non-
complementary bulge in the middle of the site. This results in the RISC/miRNA complex binding 
and holding the target mRNA and blocking translation.  
The situation with miRNAs contrasts with the function of siRNAs.  siRNAs also complex 
with RISC to regulate translation, but the resulting mechanism for mRNA silencing is different 
(Figure-1).  siRNA binds perfectly with the target site (diagram right side), and this perfect 
complementarity leads to cleavage of the mRNA at the binding site (Chu and Rana, 2006).  This 
process of targeted cleavage by RISC is known as RNA interference or RNAi (Filipowicz, 2005).  
In plants, miRNAs are more often perfectly complementary to their binding sites, and thus also 
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degrade target mRNAs through the RNAi pathway, although it is likely that plants also possess 
imperfectly binding miRNAs.  In addition to these processes, there is further evidence that the 
RISC/miRNA complex also acts to block the transcription of some genes in plants, yeast, and 
possibly in animals, by guiding the methylation of chromatin in the nucleus (Rhoades et al., 
2002). 
 
Figure 1:  RISC/miRNA-Induced mRNA Repression Versus Cleavage.  The diagram on the 
left side shows translational repression resulting from imperfect base-paired hybrids between a 
miRNA and its mRNA target sequence.  The right side shows mRNA degradation resulting from 
miRNA forming a perfect hybrid with its mRNA target.  Diagram drawn by MQP author. 
 
 It has also been shown that mRNAs containing multiple miRNA binding sites are more 
highly affected by miRNA translation regulation than those only possessing a single binding site.  
It has been shown that for mRNAs containing 2, 4, or 6 miRNA binding sites, translation 
decreases more with additional binding sites. This evidence suggests that, at least in animals, 
gene expression can be fine-tuned by varying the concentrations and types of miRNAs in the cell 
 8 
(Zeng and Cullen, 2003).  Such an miRNA network would help explain why many miRNAs 
appear to have such a wide array of functions, and why the expression of certain genes seems to 
be so complex.  The ability of some miRNAs to regulate mRNA translation but not degradation 
could help explain why gene expression based upon mRNA analysis alone does not always 
correlate specifically with protein expression (Kern et al., 2003). 
 
miRNA Production 
 The production of miRNAs is still not entirely understood.  Mounting evidence seems to 
show that miRNAs are originally transcribed as part of a primary or “Pri-miRNA” (Figure-2, see 
within the nucleus), a long single-stranded RNA molecule which forms “hairpin loop” double-
stranded structures (Lee and Ambros, 2001; Winter et al., 2009). These hairpin loops are 
processed into 70 to 100 nucleotide double-stranded “Pre-miRNA” molecules (Figure-2, 
nucleus) by the ribonuclease “Drosha” (Lee and Ambros, 2001).  These molecules are then 
transported into the cytoplasm by the export protein exportin-5 (diagram, purple), where they are 
further processed by another ribonuclease called “Dicer” (diagram, blue) (Yi et al., 2003). The 
resulting molecule is double-stranded, with one of the strands being the mature miRNA. The 
mature miRNA strand then dissociates from the double-stranded molecule (diagram, lower) and 
associates with the protein complex RISC.  This final complex of RISC and the mature miRNA 
strand is the mechanism used in mRNA regulation (Schwarz et al., 2003). 
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Figure 2:  MicroRNA Production.  Diagram shows the formation of Pri-
miRNAs, Pre-miRNAs, douoble-stranded miRNAs, and mature single-stranded 
miRNAs.  (Winter et al., 2009) 
 
Role of miRNAs in Disease 
 
 Given the wide array of genes expected to be regulated in some way by miRNAs in 
animals, it is expected that miRNAs and their mutagenesis likely plays a role in various diseases.  
It is expected that a mutation in an miRNA gene may have just as great an pathogenic role in 
genetic diseases as a mutation in a protein encoding gene.  Three different types of mutations 
should cause a malfunction in the miRNA regulation of a gene: (1) a mutation in the sequence of 
the miRNA itself, (2) a mutation in the miRNA target-binding site on an mRNA, and (3) a 
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mutation in the proteins which process and export the miRNAs to their final mature form (Meola 
et al., 2009).  
 Interestingly, it was initially argued that miRNA mutations could not play a significant 
role in genetic diseases for two main reasons. First, a mutation which would result in a complete 
failure to regulate the target mRNA(s) of a miRNA would seemingly be incompatible with the 
cell surviving at all.  And second, given the large amount of redundancy in most cells' use of 
miRNAs, a mutation in a single miRNA may not cause even a measurable change in cell 
function.  However, it has since been shown that miRNAs do indeed play a strong pathogenic 
role in the development of several genetic diseases (Meola et al., 2009). 
 One study showed that a knockdown of miRNAs expressed in cerebellar regions of mice 
results in a gradual neurodegeneration (Schaefer et al., 2007). This suggests that a mutation in 
miRNAs could easily be a cause of neurodegenerative diseases.  Another study showed that a 
knockdown of miRNA expressed in T-cells severely affects cell functionality; mice with a 
knockout of the ribonuclease “dicer”, critical in miRNA development, lose their ability to 
properly form functioning T-cells, and develop a severe auto-immune disease within weeks of 
birth (Liston et al., 2008).  This dicer knockout technique has been used to downregulate the 
expression of miRNAs in many other tissues, and the result is most often a significant 
dysfunction.  These results demonstrate the role that miRNA plays in cell development and 
function in animals, and their potential roles in diseases (Meola et al., 2009). 
 
 
Role of miRNAs in Cancer 
 
 MicroRNAs have also been implicated in the development of cancer in animals. It is 
likely that various miRNAs have multiple roles in controlling cell growth and death, so any 
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mutation in a miRNA involved in regulating growth or death pathways could lead to cancerous 
growth in vivo.  A miRNA involved in the development of cancer is called an oncomir (Meola et 
al., 2009).   
 For example, studies have shown that miRNAs derived from the miR-12-92 polycistron 
may play a role in the development of B-cell lymphomas. MicroRNAs from this locus are 
substantially elevated in tissue samples from these cancers in comparison to normal B-cell 
samples (He et al., 2005).  There is further evidence that miRNAs miR-15a and miR-16-1 are 
deleted in cases of chronic lymphocytic leukemia. The downregulation of these miRNAs results 
in a lack of regulation of downstream translation of the proto-oncogenes MCL-1 and TCL-1, 
which results in the development of leukemia in humans (Mraz et al., 2009).  These are only two 
examples of studies which have begun to show the role of miRNA in cancer, but mounting 
evidence indicates that malfunctioning miRNAs may have a role in most human cancers (Meola 
et al., 2009). 
 
MicroRNA Target Identification  
 
The bioinformatic development of a sequence library of miRNA target sites and target 
mRNAs would be a major step toward furthering miRNA research by identifying potential 
miRNA/mRNA interactions which could be subsequently proven by mutagenesis.  
Unfortunately, in animals this is particularly challenging because of the imperfect 
complementarity of the miRNA/mRNA interaction.  Moreover, only a few predicted mRNA 
targets of miRNAs have been experimentally confirmed (Wang and Wang, 2006).  Thus, a 
technique must be developed to rapidly determine which mRNAs are targeted by a specific 
miRNA.  
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Several different techniques have been studied for their effectiveness in miRNA target 
identification. Some groups have created bioinformatic algorithms which theoretically determine 
the predicted target of a miRNA based on various elements of the miRNA target recognition 
process such as sequence complementarity, binding free energy, and the level of cross-species 
conservation of the sequence (Wang and Wang, 2006).  In another approach, a gene encoding a 
specific miRNA is transfected into a desired cell line, and over-expressed to observe changes in 
cell function as quantified by microarrays, which can potentially reveal which mRNAs are 
targeted by the enhanced miRNA (Wang and Wang, 2006).  Another approach is to knock down 
the expression of a specific miRNA, then observe alterations in gene expression to predict 
mRNA targets.  Although plasmids encoding siRNAs are usually used to knock down specific 
gene expression, this RNAi process cannot be used for this purpose as the target for knock down 
is an miRNA, not a mRNA.  Thus, a different technique must be developed to knock down the 
miRNA.  Although total miRNA production can be knocked down through the genetic knockout 
of “Drosha” or “Dicer”, this does not lower production of a specific miRNA.  One possible 
approach for this purpose is to create a microRNA “sponge”. 
 
MicroRNA “Sponges” 
 
 A miRNA “sponge” is a novel technique consisting of a single-stranded mRNA with no 
translational start codon, but whose sequence contains repeated copies of a specific miRNA 
binding site. Each sponge would be able to bind and hold up to 7 miRNA copies.  Expressing the 
sponge gene in a cell could result in a decrease in the cellular levels of the target miRNA, thus 
causing the deregulation of the mRNA regulated by the miRNA.  This deregulation might 
produce a quantifiable change in the biochemistry or microarray profile of the cell, which could 
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then be measured.  Building a library of the specific targets of each miRNA would allow for a 
much greater application of miRNA research to various diseases.  
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PROJECT PURPOSE 
 
 The purpose of this MQP project is to demonstrate proof of concept in the development 
of a functioning miRNA sponge as a novel technique for decreasing the cellular levels of specific 
miRNAs to help identify their mRNA targets.  Although technically, a sponge mRNA would 
contain several miRNA-binding sequences and would not be translated (i.e. would not contain 
any translational start codon), for purposes of this project the “sponge” will consist of a 
functional firefly (FF) luciferase reporter mRNA containing multiple miRNA-binding sequences 
within its 3’ UTR to allow assay of alterations in FF luciferase activity as a measure of miRNA 
binding.   Binding sequences for microRNAs Let7 and miR122 will be used to bind their 
respective miRNAs.  When bound, we expect to see a reduced FF luciferase translation and 
activity.  A repeat sequence containing 7 copies of the Let7 or miR122 miRNA binding sites, or 
their mutated binding sites, will be inserted into plasmid pGL3, which already contains the FF 
luciferase gene, to create four experimental sponges: Let7, mut-Let7, miR122, and mut-miR122.  
After the sponge sequences have been cloned into pGL3, the Let7 sponges will be transfected 
into Huh-7 and Hela cell lines, alongside a Renilla luciferase transfection control plasmid. Once 
in the cell, the FF luciferase mRNA will be expressed containing the sponge repeat sequence 
within its 3’ UTR.  The effective binding of endogenous miRNA to the sponge will result in a 
knockdown of expression of the FF luciferase gene by blocking its translation, as quantified by a 
Promega Dual Luciferase Assay.  
 In the future, RT-PCR or Northern blots will be used to verify an unchanged level of FF 
luciferase mRNA (sequestration not degradation) under experimental conditions where the FF 
luciferase activity decreases.  In addition, miRNA Northern blots will be used to determine 
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whether the cellular levels of specific miRNAs changes detectably in the presence of the sponge.  
And in situ hybridization assays will be used to determine whether the sponge treatments alter 
mRNA localization. 
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METHODS 
 
 
Sponge Plasmid Production 
 Sponge inserts containing 7X miRNA binding sites were synthesized commercially as 
single stranded DNAs, then were annealed to make double stranded inserts containing XbaI and 
ApaI overhangs (Guanping Gao, personal communication).  The sequences of the binding sites 
for each sponge are shown in Table 1. 
Target 
miRNA 
7X miRNA-Binding Repeat Sequence 
Let7 AACTATACAAAACCTACCTCA 
mutLet7 AACTATACAAAACCTAAAGAA 
MiR122 CAAACACCATACAACACTCCA 
mutMiR122 CAAACACCATACAACAAGAAA 
 
Table 1:  miRNA-Binding Sequences for Each Experimental MicroRNA 
Sponge.  Let 7 and miR122 binding sequences are shown.  Mutant nucleotides 
are shown in red.  
 
 Firefly luciferase reporter plasmid pGL3 was doubled-digested by XbaI and ApaI to 
prepare its multiple cloning site for receiving a sponge insert. First an overnight digestion by 
ApaI was performed at 25
o
C in NEB Enzyme buffer 4 with BSA supplement. The following 
morning, XbaI was added to the digestion mix, and the temperature was raised to 37
o
C for 3 
hours to complete the digestion.   
 Each sponge insert was ligated into the XbaI-ApaI cut pGL3 using a T4 DNA Ligase 
procedure in a 20 μl total reaction volume.  2 uL of cut pGL3 at a concentration of 50 ng/μl were 
combined with 3 μl of sponge insert at a concentration of 150 ng/μl. To the mix was added 1 μl 
NEB T4 DNA Ligase and 10 µL of 10X T4 Ligase buffer. 4 μl of water were added to bring the 
reaction tube to a total of  20 µL. The ligation reaction was incubated at 16
o
C in a thermocycler 
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overnight. The ligation product was then transformed into DH5α cells, and plated to ampicillin 
plates to select for transformed cells. Colonies were picked and grown in 3 mL of LB broth. 
Qiagen mini-prep kit procedure was used to isolate plasmid DNA for sequencing. Suspended 
cells were spun down then resuspended for solution 1, 2, 3 lysis. DNA was precipitated, and 
vacuum filtration columns were used to isolate plasmid DNA.  
    
Transfection of  Cell Lines 
 Once each experimental sponge insert had been successfully cloned into pGL3, the Let7 
and mutant Let7 experimental plasmids were transfected into Huh-7 and Hela cell lines, along 
with a Renilla luciferase control plasmid pGL4.  Each experimental plasmid and control was 
mixed with Invitrogen Lipofectamine
TM
 and added to 500 μl of cell culture. Each transfection 
was allowed to incubate at 37
o
C in a CO2 incubator overnight to complete transfection. After 
transfection, the cultures were allowed to incubate for a further 72 hours to achieve expression. 
A separate cell line was transfected with pGL3 without the sponge insert as a control, and one 
culture each of Hela and Huh-7 cells were left untransfected (UTC) as negative controls.  
 
Dual Luciferase Assay 
 In order to quantify the resulting firefly and Renilla luciferase activities in the cell lines, a 
Promega Dual-Luciferase® Reporter Assay System was employed.  Each cell culture, in multi-
well plates, were mixed with Promega Passive Lysis Buffer (PBL) and shaken for 15 minutes. 
The resulting lysates were stored at 4
o
C for assay with the Dual-Luciferase Reporter Assay Kit.  
Per the instructions of the kit, the lysates were not cleared by centrifugation because it is not 
necessary.  
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 20 μl of each test sample was added to a luminometer tube containing 100 μl of 
Luciferase Assay Reagent II (LAR II), and placed into the luminometer without vortexing. This 
reagent induces luminescence from the firefly luciferase expressed from pGL3.  After recording 
the luminescence, 100 μl of Stop & Glo® Reagent was added to the reaction, vortexed quickly, 
and the tube was returned to the luminometer. This reagent quenches the luminescence of firefly 
luminescence and simultaneously induces the reaction of the Renilla luciferase for control 
luminescence (as a transfection marker).  After both readings had been taken, the sample was 
discarded and the next sample was assayed. 
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RESULTS 
 
 
Cloning Sponge Sequences Into Expression Plasmid pGL3 
 The four synthetic sponge sequence inserts (Let7, mut-Let7, miR122, and mut-miR122), 
were assembled from synthetic oligos (data not shown) to make double-stranded DNA duplexes 
for restriction digestion and cloning.  Each sponge was 121 bp long, and contained a 5’ XbaI site 
and a 3’ ApaI restriction site.  This restriction site orientation allows the sponge DNAs to be 
cloned into a matching site in firefly (FF) luciferase expression plasmid pGL3 immediately 
downstream (3’) of the Luciferase reporter to affect its mRNA’s expression.  To add an ApaI a 
restriction site to pGL3 downstream of the Luciferase reporter, a synthetic linker ~30 basepairs 
long was inserted at the XbaI restriction site (Figure-3).  With the XbaI and ApaI enzymes in 
place in pGL3, each annealed sponge assembly could then be cloned into this site with the 5’ end 
oriented upstream at the XbaI site, and the 3’ end downstream at the ApaI site.  The ApaI-
modified pGL3 was double-digested with XbaI and ApaI (data not shown), and the sponge was 
ligated into the site (Figure-3). 
After the ligation of sponge inserts into pGL3, each ligation reaction was transformed 
into competent E. coli DH5α cells, and allowed to incubate overnight on ampicillin plates to 
select for cells containing plasmids.  After overnight culture incubation, several randomly chosen 
ampicillin-resistant colonies were picked, and grown in 3mL cultures for a Qiagen
©
 miniprep. 
Following plasmid DNA extraction, each test sample was then assayed for the presence of the 
121 bp sponge insert by double restriction digestion.  The screening used a BamHI site farther 
downstream than the ApaI site, so positives should produce a fragment approximately 600 bp 
long, while negatives produce a fragment approximately 500 bp long.  The plasmids were double 
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digested with XbaI/BamHI,  and analyzed by gel electrophoresis alongside digested and 
undigested parental pGL3 for comparison (data not shown).   
Positive plasmids containing sponge inserts were confirmed by sending the samples for 
sequence analysis by Operon Inc. and their SimpleSeq
TM
 service.   The sequencing results (data 
not shown) indicated that all positives contained the expected four sponge sequences.  Selected 
positives were then used to grow 2 liter cultures for large scale plasmid isolations and CsCl 
gradients to produce high quality plasmid DNA for performing mammalian cell transfections. 
 
 
Figure 3: Diagram of Expression Plasmid pGL3 Containing a Let7 Sponge Downstream 
from Luciferase.  The diagram shows the pGL3 parental plasmid containing a luciferase reporter 
gene (orange, diagram right) with a Let7 sponge sequence (green arrow) cloned into the 
XbaI/ApaI site immediately downstream of the reporter.  The sponge sequence lies upstream of 
the poly(A) transcription termination signal (green line), so it will be present within the 3’ UTR of 
the luciferase mRNA where it will bind endogenous cellular Let7 miRNA to induce blockage of 
luciferase mRNA translation. 
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Cell Transfections and Luciferase Assays 
 CsCl-purified plasmid DNAs were transfected into two types of mammalian cell lines, 
Huh7 and Hela cells.  These two cell lines were chosen because they each contain the target 
miRNA Let7, whereas cell lines such as HEK293 do not.  The cells were also double transfected 
with a Renilla luciferase reporter plasmid to monitor transfection efficiency.  Following 72 hrs of 
incubation to ensure expression of the Luciferase reporter (mRNA and protein), cell lysates were 
prepared and assayed for each type of Luciferase (firefly luciferase from the engineered pGL3 
containing the miRNA sponges, and Renilla luciferase) using a Dual-Luciferase Assay 
(Promega
®
). The average luminescence for each experimental sample was measured in triplicate, 
and the mean is shown in Figure-4. 
 
 
Figure 4: Average Luminescence of Each Transfected Cell Line.  A dual 
luciferase assay was performed for firefly luciferase (FF) (expressed from the 
engineered pGL3 containing the sponge sequences), and for renilla luciferase (RN) 
(expressed from the transfection control plasmid).  Each histobar represents the 
mean of three observations.  Error bars denote standard error.  FF luciferase activity 
was found to be high in parental pGL3 and Mut-Let7 plasmids (not binding 
miRNA), and low in Let7 plasmid or untransfected cells (UTC).  The Renilla 
control luciferase is similar in each cell line.   
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 For each cell line, Firefly (FF) luciferase activity (expressed from pGL3) is high in 
parental pGL3 and in Mut-Let7 plasmids, neither of which contains a Let7 miRNA binding site.  
And FF luciferase activity is low in the Let7 plasmid and in untransfected cells (UTC).  The 
activity of the Renilla control luciferase is similar in each cell line.  The low level of FF 
luciferase observed for the Let7 plasmid likely results from luciferase mRNA sequesteration 
induced by endogenous cellular miRNA Let7 binding its sponge sequence at the 3’ UTR of the 
mRNA.  Thus, the data indicates that the Let7 sponge was highly effective in binding 
endogenous Let7 in each cell line, and the binding was sequence specific.  
 Due to time constraints, the miR122 sponge cloned as a part of this project was not 
tested, nor were the cellular levels of luciferase mRNA as assayed by RT-PCR. 
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DISCUSSION 
 
 
 
The data shown in this project demonstrate that the microRNA sponge technique applied 
to miRNA Let7 was effective in binding and holding endogenous miRNA in vitro, as evidenced 
by the decreased activity of Firefly (FF) luciferase expressed from the mRNA containing seven 
Let7 binding sequences in its 3’ UTR.  A clear decreased activity of FF luciferase was observed 
in each human cell line transfected with the Let7 plasmid, but not for cells transfected with the 
mutant Let7 plasmid, indicating base-pairing interactions are required for the activity decrease.  
Let7 binding sites perfectly complementary to Let7 miRNA should be more effective in the 
decrease than mutated binding sites that bind miRNA less efficiently. 
This data shows that the miRNA sponge concept is effective and has potential for future 
applications in vivo for both miRNA research and therapeutics. The ability of this technique to 
decrease cellular levels of specific miRNAs should help determine the effects of the depletion on 
genes affected by specific miRNAs.  A bioinformatics approach for theoretically identifying 
potential miRNA binding sites in the UTRs of mRNAs has a somwhat limited potential (Wang 
and Wang, 2006).  The sponge technique should allow for faster and easier identification of 
target sites to aid our understanding and use of miRNAs, instead of creating genetic knockouts or 
generating complex bioinformatic algorithms (Wang and Wang, 2006). 
The work performed in this project encountered some difficulties.  The Let7, mut-Let7, 
and mut-miR122 sponge sequences were all cloned into plasmid pGL3 within the first month of 
the project, however the miR122 sequence remained stubborn. Repeated ligations, 
transformations, and screenings yielded many plasmid DNA samples containing a ~121 bp 
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insert, but whose sequence did not match that of the purchased synthetic DNA oligos. This 
problem continued for several months until a second set of miR122 sponge inserts was annealed 
and cloned into the plasmid successfully.  
This cloning problem led to this project ceasing at the proof of concept stage.  Not tested 
in the luciferase assays were either of the two cloned miR22 plasmids.  Nor was RT-PCR used to 
assay the cellular levels of luciferase mRNA to determine whether the levels remained 
unchanged (sequestered) as translation decreased.  Also not tested was the RT-PCR of any 
mRNA known to be affected by cellular levels of Let7 or miR122 to determine whether a 
lowering of specific miRNAs had indeed occurred.   
Allowed more time, this project could also have moved into in vivo studies with mice to 
determine whether infection with viruses engineered with sponge sequences affect gene 
expression patterns in mice.  So the next step in the development of this technique involves the 
incorporation of sponge sequences into an Adeno-Associated Virus (AAV) gene therapy vector.  
The AAV vector is a new developing technique for gene therapy which takes advantage of the 
inability of AAV to recombine with host DNA to reconstitute its pathogenicity.   AAV also has 
an extremely low risk of insertion near any known oncogene, making it very promising as a gene 
therapy vector. The use of AAV vectors to deliver miRNA sponges in vivo will allow the effects 
of miRNA lowering on complex organ systems.  The next target for research in vivo is a family 
of miRNAs known to be involved in the development of familial hypercholesterolemia. The 
sponge will be used to knockdown overexpressed levels of an miRNA which helps cause the 
disease. This potential therapeutic use would be a major development in our understanding of the 
role of miRNA in disease, and potential treatments for diseases. 
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